Trials / Completed
CompletedNCT06693154
Calprotectin Levels in Necrotizing Enterocolitis
A Comparative Study of Serum and Fecal Calprotectin Levels in Necrotizing Enterocolitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- Ankara Yildirim Beyazıt University · Academic / Other
- Sex
- All
- Age
- 3 Days – 30 Days
- Healthy volunteers
- Not accepted
Summary
Necrotizing enterocolitis (NEC) is a serious condition that can affect premature babies, leading to complications like intestinal damage and infection. In our study, we measured specific markers (called calprotectin) in blood and stool to understand how severe NEC is and predict outcomes. We found that these markers were higher in babies with more severe NEC (stage 3), especially in those who needed surgery or sadly did not survive. This information can help doctors detect NEC earlier, understand its severity, and make better decisions for treating affected babies.
Conditions
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2024-01-01
- Completion
- 2024-06-01
- First posted
- 2024-11-18
- Last updated
- 2024-11-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06693154. Inclusion in this directory is not an endorsement.